Skip to main content

DIADEMA PARTNERS LP

Position in QURE — uniQure N.V.

CIK 2026172 MORRISTOWN, NJ

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$510,120
-$566,730 QoQ
Shares Held
31,200
-30.7% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Mar 31, 2026
CallValue
$4,087,500
CallShares
250,000
PutValue
$4,888,650
PutShares
299,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DIADEMA PARTNERS LP holds $177,237,458 across 73 Biotechnology names. QURE ranks #50 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in QURE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,888,650 299,000
2026-03-31 $4,087,500 250,000
2026-03-31 $510,120 31,200
2025-12-31 $7,222,074 301,800
2025-12-31 $1,076,850 45,000
2025-09-30 $17,511,000 300,000
2025-06-30 $1,451,154 104,100
2025-03-31 $1,633,460 154,100
2025-03-31 $386,900 36,500
2024-12-31 $1,766,000 100,000